Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
27.04.2023 11:45:00

Dominari Financial CEO, Kyle Wool, Scheduled to Appear on Fox Business Network's "Mornings with Maria" on April 27

NEW YORK, April 27, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced that Kyle Wool, CEO of Dominari Financial Inc. ("Dominari Financial"), a wholly owned subsidiary of the Company, is scheduled to appear as a guest on Fox Business Network's show "Mornings with Maria" early in the 6-7 a.m. hour on April 27th to discuss global economic trends and what it means for investors.

Dominari Holdings Logo (PRNewsfoto/Dominari Holdings Inc.)

Mr. Wool is a successful Wall Street veteran, having held numerous positions across leading firms in private wealth management and asset management. At Dominari Financial, he is focused on building a dynamic and modern financial services organization that is at the forefront of wealth creation and preservation.

Prior to his appointment as CEO of Dominari Financial, Mr. Wool served as an Executive Director of Wealth Management at Morgan Stanley, where he distinguished himself as the top producer globally for one of finance's leading institutions. Earlier in his career, he was based in Hong Kong where he served as Managing Director of the Professional Investors Group for Oppenheimer Asia Ltd., one of the youngest executives to have led the region.

Dominari Financial Inc.'s Mission Statement:

Dominari Financial is a dynamic, forward-thinking financial services company that seeks to create wealth for all stakeholders by capitalizing on emerging trends in the financial services sector and identifying early-stage future opportunities that are expected to generate a high rate of return for investors.

Dominari Financial offers Securities Brokerage and Registered Investment Adviser Services through Dominari Securities LLC, its wholly-owned subsidiary, and a Member of FINRA, MSRB, and SIPC. Securities brokerage, investment adviser and other non-bank deposit investments are not FDIC-insured and may lose some or all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at https://brokercheck.finra.org.  

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, which include but are not limited to the Risk Factors set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 relating to its business. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:
Investor Relations
Hayden IR
Brett Maas, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dominari-financial-ceo-kyle-wool-scheduled-to-appear-on-fox-business-networks-mornings-with-maria-on-april-27-301809044.html

SOURCE Dominari Holdings Inc.

Nachrichten zu AIkido Pharma Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu AIkido Pharma Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

AIkido Pharma Inc Registered Shs 1,43 0,70% AIkido Pharma Inc Registered Shs